28 min listen
Red Flags in the Pharmacy Law Jungle | PAIN POD
FromPain Pod
ratings:
Length:
43 minutes
Released:
Dec 16, 2021
Format:
Podcast episode
Description
On this episode of the PAIN POD, Mark Pain Guy Garofoli will chat with Dr. David Brushwood, a world-renowned pharmacy law expert, about all things pain management, controlled substances, drug diversion, and pharmacy law. You may be sitting down listening, but it turns out you’ll only be using the edge of the seat! Corresponding legal responsibility, check. Professional conversations between prescribers and dispensers alike, check. DEA Red Flags, check. An attempted prescription from a zoo, check, wait, what? Yes, check. You name it, if it’s pharmacy law and pain management related, it’s discussed, right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!
DEA Red Flags Info
Prescribers
Cash only patients and/or no acceptance of worker’s compensation or insurance
Prescribing of the same combination of highly-abused medications
Prescribing the same (high) quantities of pain drugs to most/every patient
High number of prescriptions issued per day
Geographically out-of-area patient population
Dispensers
High percentage controlled to non-controlled medications
High volumes of controlled substances generally
Same Medication(s)/Quantities prescribed by the same prescriber for many patients
Large geographical distances between pharmacy, prescriber(s), and patient
Multiple patients with the same last name or address
Sequential prescription #s for highly diverted drugs from the same prescriber
Patients receiving controlled substances from multiple prescribers
Patients seeking early prescription refills paying out-of-pocket
NABP ”Red Flags” Video
https://nabp.pharmacy/initiatives/awarxe/pharmacist-resources/
Learn more about your ad choices. Visit megaphone.fm/adchoices
DEA Red Flags Info
Prescribers
Cash only patients and/or no acceptance of worker’s compensation or insurance
Prescribing of the same combination of highly-abused medications
Prescribing the same (high) quantities of pain drugs to most/every patient
High number of prescriptions issued per day
Geographically out-of-area patient population
Dispensers
High percentage controlled to non-controlled medications
High volumes of controlled substances generally
Same Medication(s)/Quantities prescribed by the same prescriber for many patients
Large geographical distances between pharmacy, prescriber(s), and patient
Multiple patients with the same last name or address
Sequential prescription #s for highly diverted drugs from the same prescriber
Patients receiving controlled substances from multiple prescribers
Patients seeking early prescription refills paying out-of-pocket
NABP ”Red Flags” Video
https://nabp.pharmacy/initiatives/awarxe/pharmacist-resources/
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Dec 16, 2021
Format:
Podcast episode
Titles in the series (16)
Mark Garofoli, PharmD | PAIN POD: PAIN POD EPISODE 0 One of the most common definitions of pain describes pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” When we are exposed to something that causes pain, if able, we quickly or reflexively withdraw. The sensory feeling of pain is called nociception. What Does It Mean to Call Chronic Pain a Brain Disease? by Mark D. Sullivan https://www.jpain.org/article/S1526-5900(12)00560-3/pdf Multiple investigators have recently asked whether neuroimaging has shown that chronic pain is a brain disease. We review the clinical implications of seeing chronic pain as a brain disease. Abnormalities noted on imaging of peripheral structures have previously misled the clinical care of patients with chronic pain. We also cannot assume that the changes associated with chronic pain on neuroimaging are causal. When considering the significance of neuroimaging by Pain Pod